Cuba vs Latvia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Cuba
27 patients
in 2021
Latvia
35 patients
in 2017
Cuba rank
96th
Latvia rank
93rd
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Cuba
- Latvia
How they compare
Latvia currently reports 35 patients against 27 patients in Cuba, a difference of 8 patients.
That makes Latvia's figure about 1.3 times Cuba's.
The two have swapped places 3 times across 12 shared years of data; in 2006 it was Latvia ahead.
Cuba ranks 96th and Latvia ranks 93rd of 183 countries.
Across the 2 decades both report, Cuba averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | Cuba | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.5 patients | 32.75 patients | 13.25 patients | Latvia |
| 2010s | 60.12 patients | 48 patients | 12.12 patients | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Cuba or Latvia?
- Latvia, at 35 patients against 27 patients in Cuba as of 2017.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Cuba and Latvia?
- 8 patients, with Latvia ahead.
- How many years of comparable data are there for Cuba and Latvia?
- 12 years are reported by both, from 2006 to 2017.
- How do Cuba and Latvia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Cuba ranks 96th and Latvia ranks 93rd of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.